{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:44:23Z","timestamp":1790315063252,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.ejca.2016.06.002","type":"journal-article","created":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T12:20:46Z","timestamp":1469535646000},"page":"69-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":86,"special_numbering":"C","title":["Diffuse malignant peritoneal mesothelioma: Evaluation of systemic chemotherapy with comprehensive treatment through the RENAPE Database"],"prefix":"10.1016","volume":"65","author":[{"given":"V.","family":"Kepenekian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Elias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Passot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Mery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Goere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Delroeux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Quenet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Ferron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Pezet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Guilloit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Meeus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Pocard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Bereder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Abboud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Arvieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Brigand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Marchal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Classe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Lorimier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"De Chaisemartin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Guyon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Mariani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Ortega-Deballon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Isaac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Maurice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.N.","family":"Gilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2802-4974","authenticated-orcid":false,"given":"O.","family":"Glehen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Averous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Bereder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Bibeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Bouzard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Chevallier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Croce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Dartigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Durand-Fontanier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Gouthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Heyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Kaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Kianmanesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.H.","family":"Laverri\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Leblanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Lelong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Leroux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Loi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Mariette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Meeus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Msika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Pezet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Peyrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Pirro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Paineau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Poizat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Porcheron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Quenet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Rat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Regimbeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Thibaudeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.J.","family":"Tuech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Valmary-Degano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Verriele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Zerbib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Zinzindohoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2016.06.002_bib1","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/path.1700120212","article-title":"A malignant tumour arising from the endothelium of the peritoneum, and producing a mucoid ascitic fluid","volume":"12","author":"Miller","year":"1908","journal-title":"J Pathol"},{"key":"10.1016\/j.ejca.2016.06.002_bib2","first-page":"5","article-title":"Asbestos cancers","volume":"46","author":"Wagner","year":"1971","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2016.06.002_bib3","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/annonc\/mdl345","article-title":"Epidemiology of peritoneal mesothelioma: a review","volume":"18","author":"Boffetta","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2016.06.002_bib4","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0140-6736(85)90526-4","article-title":"Early peritoneal mesothelioma: a treatable malignancy","volume":"326","author":"Antman","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2016.06.002_bib5","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1056\/NEJMra050152","article-title":"Advances in malignant mesothelioma","volume":"353","author":"Robinson","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2016.06.002_bib6","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/annonc\/mdp307","article-title":"Malignant peritoneal mesothelioma: a multicenter study on 81 cases","volume":"21","author":"Manzini","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2016.06.002_bib7","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/0002-9343(80)90103-5","article-title":"Multimodality therapy for malignant mesothelioma based on a study of natural history","volume":"68","author":"Antman","year":"1980","journal-title":"Am J Med"},{"key":"10.1016\/j.ejca.2016.06.002_bib8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.lungcan.2008.08.013","article-title":"Malignant peritoneal mesothelioma-results from the International Expanded Access Program using pemetrexed alone or in combination with a platinum agent","volume":"64","author":"Carteni","year":"2009","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ejca.2016.06.002_bib9","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3816\/CLC.2005.n.020","article-title":"Open-label study of pemetrexed alone or in combination with cisplatin for the treatment of patients with peritoneal mesothelioma: outcomes of an expanded access program","volume":"7","author":"J\u00e4nne","year":"2005","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.ejca.2016.06.002_bib10","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.ejso.2006.03.009","article-title":"Systemic chemotherapy in the management of malignant peritoneal mesothelioma","volume":"32","author":"Garcia-Carbonero","year":"2006","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejca.2016.06.002_bib11","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0140-6736(79)92937-4","article-title":"Intracavitary doxorubicin in malignant effusions","volume":"1","author":"Tattersall","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2016.06.002_bib12","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/1097-0142(197309)32:3<656::AID-CNCR2820320319>3.0.CO;2-U","article-title":"Long-term survival in patients with malignant peritoneal mesothelioma treated with irradiation","volume":"32","author":"Rogoff","year":"1973","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2016.06.002_bib13","doi-asserted-by":"crossref","first-page":"6237","DOI":"10.1200\/JCO.2009.23.9640","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience","volume":"27","author":"Yan","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2016.06.002_bib14","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1016\/j.ejca.2013.05.027","article-title":"Diffuse malignant peritoneal mesothelioma: long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"49","author":"Baratti","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2016.06.002_bib15","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.5858\/133.8.1317","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group","volume":"133","author":"Husain","year":"2009","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ejca.2016.06.002_bib16","doi-asserted-by":"crossref","first-page":"647","DOI":"10.5858\/arpa.2012-0214-OA","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group","volume":"137","author":"Husain","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ejca.2016.06.002_bib17","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1245\/s10434-007-9475-8","article-title":"Multicystic and well-differentiated papillary peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC)","volume":"14","author":"Baratti","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2016.06.002_bib18","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1002\/cncr.25640","article-title":"A novel tumor-node-metastasis (TNM) staging system of diffuse malignant peritoneal mesothelioma using outcome analysis of a multi-institutional database","volume":"117","author":"Yan","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2016.06.002_bib19","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ctrv.2011.10.006","article-title":"Diffuse malignant peritoneal mesothelioma \u2013 an update on treatment","volume":"38","author":"Mirarabshahii","year":"2012","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ejca.2016.06.002_bib20","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1200\/JCO.2007.15.2868","article-title":"Pemetrexed plus gemcitabine as first-line chemotherapy for patients with peritoneal mesothelioma: final report of a phase II trial","volume":"26","author":"Simon","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2016.06.002_bib21","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1245\/s10434-012-2845-x","article-title":"The role of perioperative systemic chemotherapy in diffuse malignant peritoneal mesothelioma patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"20","author":"Deraco","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2016.06.002_bib22","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.annpat.2014.01.008","article-title":"The RENAPE network: towards a new healthcare organization for the treatment of rare tumors of the peritoneum. Description of the network and role of the pathologists","volume":"34","author":"Villeneuve","year":"2014","journal-title":"Ann Pathol"},{"key":"10.1016\/j.ejca.2016.06.002_bib23","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ejca.2016.06.002_bib24","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","article-title":"Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis","volume":"82","author":"Jacquet","year":"1996","journal-title":"Cancer Treat Res"},{"key":"10.1016\/j.ejca.2016.06.002_bib25","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00000658-199501000-00004","article-title":"Peritonectomy procedures","volume":"221","author":"Sugarbaker","year":"1995","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejca.2016.06.002_bib26","unstructured":"The National Cancer Institute's Common Terminology Criteria for Adverse Events v3.0 update. http:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/docs\/ctcaev3.pdf."},{"key":"10.1016\/j.ejca.2016.06.002_bib27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4251\/wjgo.v2.i1.31","article-title":"Selection of patients and staging of peritoneal surface malignancies","volume":"2","author":"Cotte","year":"2010","journal-title":"World J Gastrointest Oncol"},{"key":"10.1016\/j.ejca.2016.06.002_bib28","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0169-5002(02)00180-0","article-title":"Activity of chemotherapy and immunotherapy on malignant mesothelioma: a systematic review of the literature with meta-analysis","volume":"38","author":"Berghmans","year":"2002","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ejca.2016.06.002_bib29","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1200\/JCO.2003.04.150","article-title":"Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy","volume":"21","author":"Feldman","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2016.06.002_bib30","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.ejso.2006.03.012","article-title":"Comprehensive management of diffuse malignant peritoneal mesothelioma","volume":"32","author":"Sugarbaker","year":"2006","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejca.2016.06.002_bib31","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1245\/s10434-006-9169-7","article-title":"Prognostic indicators for patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma\u2020","volume":"14","author":"Yan","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2016.06.002_bib32","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1245\/s10434-008-0219-1","article-title":"Diffuse malignant peritoneal mesothelioma: failure analysis following cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"16","author":"Baratti","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2016.06.002_bib33","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/jso.21177","article-title":"Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: the Australian experience","volume":"99","author":"Chua","year":"2009","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ejca.2016.06.002_bib34","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1245\/s10434-014-3977-y","article-title":"Iterative cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent or progressive diffuse malignant peritoneal mesothelioma: clinicopathologic characteristics and survival outcome","volume":"22","author":"Ihemelandu","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2016.06.002_bib35","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1245\/s10434-013-3358-y","article-title":"Malignant peritoneal mesothelioma: prognostic factors and oncologic outcome analysis","volume":"21","author":"Magge","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2016.06.002_bib36","series-title":"Manual of clinical oncology","first-page":"202","article-title":"Systemic therapies","author":"Trump","year":"1994"},{"key":"10.1016\/j.ejca.2016.06.002_bib37","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1182\/blood-2008-08-175125","article-title":"Tumor burden influences exposure and response to rituximab: pharmacokinetic-pharmacodynamic modeling using a syngeneic bioluminescent murine model expressing human CD20","volume":"113","author":"Dayd\u00e9","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2016.06.002_bib38","doi-asserted-by":"crossref","first-page":"e63078","DOI":"10.1371\/journal.pone.0063078","article-title":"Tumor burden talks in cancer treatment with PEGylated liposomal drugs","volume":"8","author":"Lin","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejca.2016.06.002_bib39","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2016.06.002_bib40","series-title":"Food and drug administration website","author":"Guidance for Industry Expanded Access to Investigational Drugs for Treatment Use \u2013 Qs & As","year":"2014"},{"key":"10.1016\/j.ejca.2016.06.002_bib41","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.lungcan.2011.04.014","article-title":"Chemotherapy and targeted therapies for unresectable malignant mesothelioma","volume":"73","author":"Kelly","year":"2011","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ejca.2016.06.002_bib42","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","article-title":"Safety and activity of anti-PD-L1 antibody in patients with advanced cancer","volume":"366","author":"Brahmer","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2016.06.002_bib43","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/jama.286.7.821","article-title":"Comparison of evidence of treatment effects in randomized and nonrandomized studies","volume":"286","author":"Ioannidis","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ejca.2016.06.002_bib44","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/SLA.0000000000000256","article-title":"Comparison of treatment effect estimates from prospective nonrandomized studies with propensity score analysis and randomized controlled trials of surgical procedures","volume":"259","author":"Lonjon","year":"2014","journal-title":"Ann Surg"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804916321918?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804916321918?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T20:56:15Z","timestamp":1656881775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804916321918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":44,"alternative-id":["S0959804916321918"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2016.06.002","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diffuse malignant peritoneal mesothelioma: Evaluation of systemic chemotherapy with comprehensive treatment through the RENAPE Database","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2016.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}